title: Aspirin with or without an antiemetic for acute migraine headaches in adults.
abstract: BACKGROUND
  Migraine is a common, disabling condition and a burden for the individual, health services and society. Many sufferers choose not to, or are unable to, seek professional help and rely on over-the-counter analgesics. Co-therapy with an antiemetic should help to reduce nausea and vomiting commonly associated with migraine headaches.
  
  
  OBJECTIVE
  To determine the efficacy and tolerability of aspirin, alone or in combination with an antiemetic, compared to placebo and other active interventions in the treatment of acute migraine headaches in adults.
  
  
  METHODS
  We searched Cochrane CENTRAL, MEDLINE, EMBASE and the Oxford Pain Relief Database for studies through 10 March 2010.
  
  
  METHODS
  We included randomised, double-blind, placebo- or active-controlled studies using aspirin to treat a discrete migraine headache episode, with at least 10 participants per treatment arm.
  
  
  METHODS
  Two review authors independently assessed trial quality and extracted data. Numbers of participants achieving each outcome were used to calculate relative risk and numbers needed to treat (NNT) or harm (NNH) compared to placebo or other active treatment.
  
  
  RESULTS
  Thirteen studies (4222 participants) compared aspirin 900 mg or 1000 mg, alone or in combination with metoclopramide 10 mg, with placebo or other active comparators, mainly sumatriptan 50 mg or 100 mg. For all efficacy outcomes, all active treatments were superior to placebo, with NNTs of 8.1, 4.9 and 6.6 for 2-hour pain-free, 2-hour headache relief, and 24-hour headache relief with aspirin alone versus placebo, and 8.8, 3.3 and 6.2 with aspirin plus metoclopramide versus placebo. Sumatriptan 50 mg did not differ from aspirin alone for 2-hour pain-free and headache relief, while sumatriptan 100 mg was better than the combination of aspirin plus metoclopramide for 2-hour pain-free, but not headache relief; there were no data for 24-hour headache relief.Associated symptoms of nausea, vomiting, photophobia and phonophobia were reduced with aspirin compared with placebo, with additional metoclopramide significantly reducing nausea (P < 0.00006) and vomiting (P = 0.002) compared with aspirin alone.Fewer participants needed rescue medication with aspirin than with placebo. Adverse events were mostly mild and transient, occurring slightly more often with aspirin than placebo.
  
  
  CONCLUSIONS
  Aspirin 1000 mg is an effective treatment for acute migraine headaches, similar to sumatriptan 50 mg or 100 mg. Addition of metoclopramide 10 mg improves relief of nausea and vomiting. Adverse events were mainly mild and transient, and were slightly more common with aspirin than placebo, but less common than with sumatriptan 100 mg.
authors.affiliation: Pain Research and Nuffield Department of Anaesthetics, University of Oxford, West Wing (Level 6), John Radcliffe Hospital, Oxford, Oxfordshire, UK, OX3 9DU.
authors.forename: Varo
authors.initials: V
authors.lastname: Kirthi
authors.forename: Sheena
authors.initials: S
authors.lastname: Derry
authors.forename: R Andrew
authors.initials: RA
authors.lastname: Moore
authors.forename: Henry J
authors.initials: HJ
authors.lastname: McQuay
mesh_terms: D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D000932:Antiemetics / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use*; D004359:Drug Therapy, Combination / Q000379:methods; D006801:Humans; D008787:Metoclopramide / Q000627:therapeutic use; D008881:Migraine Disorders / Q000150:complications / Q000188:drug therapy*; D009325:Nausea / Q000188:drug therapy / Q000209:etiology; D020795:Photophobia / Q000188:drug therapy / Q000209:etiology; D016032:Randomized Controlled Trials as Topic; D018170:Sumatriptan / Q000627:therapeutic use; D014839:Vomiting / Q000188:drug therapy / Q000209:etiology
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000932:Antiemetics; D018170:Sumatriptan; D008787:Metoclopramide; D001241:Aspirin
references.citation: Cephalalgia. 2008 Sep;28 Suppl 2:28-35
references.pmid: 18715330
references.citation: Eur J Clin Pharmacol. 1983;24(6):777-85
references.pmid: 6884416
references.citation: J Clin Pharm Ther. 2009 Apr;34(2):177-86
references.pmid: 19250138
references.citation: Eur Neurol. 1999 Jan;41(1):37-43
references.pmid: 9885327
references.citation: Control Clin Trials. 1996 Feb;17(1):1-12
references.pmid: 8721797
references.citation: BMJ. 2004 Dec 11;329(7479):1369-73
references.pmid: 15550401
references.citation: Value Health. 2009 Jan-Feb;12(1):55-64
references.pmid: 18671771
references.citation: Pharmacoeconomics. 1997;11 Suppl 1:1-10
references.pmid: 10168038
references.citation: J Fam Pract. 1996 Jan;42(1):36-42
references.pmid: 8537803
references.citation: Pain. 1998 Dec;78(3):209-216
references.pmid: 9870574
references.citation: Can J Neurol Sci. 1993 May;20(2):131-7
references.pmid: 8334575
references.citation: Cephalalgia. 2000 Nov;20(9):765-86
references.pmid: 11167908
references.citation: Eur J Neurol. 2009 Sep;16(9):968-81
references.pmid: 19708964
references.citation: Headache. 1994 Jun;34(6):337-43
references.pmid: 7928312
references.citation: J Neurol. 2007 Jun;254(6):705-12
references.pmid: 17406776
references.citation: Br Med J. 1974 Nov 2;4(5939):265-8
references.pmid: 4425854
references.citation: Cephalalgia. 1994 Aug;14(4):297-300
references.pmid: 7954760
references.citation: Cephalalgia. 2004 Nov;24(11):947-54
references.pmid: 15482357
references.citation: Br Med J (Clin Res Ed). 1988 May 7;296(6632):1313-6
references.pmid: 3133061
references.citation: Presse Med. 1995 Feb 4;24(5):254-8
references.pmid: 7899379
references.citation: Headache. 2002 Apr;42(4):249-55
references.pmid: 12010380
references.citation: BMJ. 1995 Feb 18;310(6977):452-4
references.pmid: 7873954
references.citation: Br J Clin Pharmacol. 1975 Feb;2(1):57-63
references.pmid: 791318
references.citation: Cephalalgia. 1984 Jun;4(2):107-11
references.pmid: 6375873
references.citation: Headache. 2005 Apr;45(4):283-92
references.pmid: 15836564
references.citation: BMJ. 1997 Sep 13;315(7109):635-40
references.pmid: 9310564
references.citation: Pharmacoeconomics. 1998 Jun;13(6):667-76
references.pmid: 10179702
references.citation: Ann Intern Med. 1987 Aug;107(2):224-33
references.pmid: 3300460
references.citation: Arch Intern Med. 1999 Apr 26;159(8):813-8
references.pmid: 10219926
references.citation: Arch Intern Med. 1999 Apr 26;159(8):857-63
references.pmid: 10219932
references.citation: Pain. 2002 Jun;97(3):247-257
references.pmid: 12044621
references.citation: Expert Rev Neurother. 2006 Apr;6(4):563-73
references.pmid: 16623655
references.citation: Rev Neurol. 2008 Nov 16-30;47(10):506-8
references.pmid: 19012253
references.citation: Cephalalgia. 2005 Oct;25(10):776-87
references.pmid: 16162254
references.citation: Headache. 2007 Mar;47(3):355-63
references.pmid: 17371352
references.citation: Neurology. 2007 Jan 30;68(5):343-9
references.pmid: 17261680
references.citation: Acta Neurol Belg. 2007 Sep;107(3):84-90
references.pmid: 18072336
references.citation: QJM. 1996 Jan;89(1):77-84
references.pmid: 8730346
references.citation: Headache. 2008 Apr;48(4):601-5
references.pmid: 18377382
references.citation: Cephalalgia. 1988;8 Suppl 7:1-96
references.pmid: 3048700
references.citation: Cephalalgia. 2000 Sep;20(7):663-7
references.pmid: 11128825
references.citation: Lancet. 1995 Oct 7;346(8980):923-6
references.pmid: 7564725
references.citation: Cephalalgia. 1995 Dec;15(6):531-5
references.pmid: 8706118
references.citation: Neurology. 2008 Aug 19;71(8):559-66
references.pmid: 18711108
references.citation: Headache. 2006 May;46(5):715-25
references.pmid: 16643573
references.citation: Headache. 2009 Jan;49(1):79-89
references.pmid: 19125877
references.citation: Eur Neurol. 1980;19(3):163-5
references.pmid: 7389761
references.citation: Pain. 1996 Aug;66(2-3):239-46
references.pmid: 8880846
references.citation: Eur Neurol. 1992;32(3):177-84
references.pmid: 1317294
references.citation: Cephalalgia. 1994 Apr;14(2):156-61
references.pmid: 8062355
references.citation: Nat New Biol. 1971 Jun 23;231(25):232-5
references.pmid: 5284360
references.citation: Curr Opin Neurol. 2008 Jun;21(3):331-7
references.pmid: 18451718
references.citation: Cephalalgia. 2004;24 Suppl 1:9-160
references.pmid: 14979299
references.citation: Eur Neurol. 1999;41(2):88-93
references.pmid: 10023111
references.citation: BMJ. 2000 Nov 11;321(7270):1183-7
references.pmid: 11073508
references.citation: Eur Neurol. 2004;52(1):50-6
references.pmid: 15240983
references.citation: Eur Neurol. 2002;47(2):88-98
references.pmid: 11844897